abc27

Breakthrough clinical trial confirms that GammaTile delivers superior tumor control compared to standard of care for patients with newly diagnosed operable brain metastases

Immediate, targeted radiation at the time of surgery reduces the risk of tumor recurrence or death by greater than 50% compared to standard of care in early clinical data readout TEMPE, Ariz., Oct. 21 ...
Fred Hutchinson Cancer Center

Protecting what matters most: Proton therapy for brain and central nervous system tumors

Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...
Morningstar

GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma

GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into ...
Medical Xpress

Different types of brain tumors: What they are, how they present and what to expect

Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the brain from cancer elsewhere). They can also ...
Morningstar

GT Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

TEMPE, Ariz., Dec. 30, 2025 /PRNewswire/ -- GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, announced today that Per Langoe, ...
WWLP-22News

GT Medical Technologies Completes Final Close of Company's Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain ...

TEMPE, Ariz., July 15, 2025 /PRNewswire/ -- GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced the company has ...